What role does CYP1A2 play in fatigue?

The role of CYP1A2 in fatigue is not directly established but is indirectly linked through caffeine metabolism. CYP1A2 is the primary enzyme responsible for metabolizing caffeine in the liver. Individuals with a slow-metabolizing variant (e.g., rs762551, genotype AA) break down caffeine more slowly, which can lead to prolonged wakefulness or, conversely, sleep disturbances—but not a direct reduction in fatigue. The relationship between caffeine and fatigue is complex: caffeine temporarily blocks adenosine receptors, promoting alertness, but regular use can lead to tolerance. A DNA test for CYP1A2 can indicate how quickly you process caffeine, but the impact on fatigue is heavily influenced by lifestyle, sleep hygiene, and other genetic factors. Evidence for a direct link between CYP1A2 variants and chronic fatigue is weak; most studies show small, clinically non-significant effects. Therefore, fatigue should not be attributed solely to CYP1A2. Note: The provided context contains no specific data on CYP1A2 or fatigue.